Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Jun 29, 2007

Rimonabant Regulatory Update in the United States
Jun 27, 2007

Taxotere® (docetaxel) Granted FDA Priority Review for Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck Prior to Chemoradiotherapy and Surgery
Jun 24, 2007

Apidra® Improved A1C In People With Type 2 Diabetes When Added to Basal Insulin And Oral Antidiabetic Treatments (BOT)
Jun 23, 2007

Results of Two Head-to-Head Studies Demonstrated Long-Acting Insulin Lantus® Lowered Free Fatty Acid Levels Equal to or Better
Jun 21, 2007

Basketball Hall of Fame Coach Chuck Daly Creates Game Plan to Manage the Symptoms of Benign Prostatic Hyperplasia (BPH)
Jun 20, 2007

Sanofi Pasteur Announces Completion of Construction of New U.S. Influenza Vaccine Manufacturing Facility

Sanofi pasteur Leads the Way in Influenza Vaccine Supply and Pandemic Preparedness
Jun 19, 2007

Sanofi-aventis and Bristol-Myers Squibb Prevail in U.S. Plavix® Patent Litigation
Jun 15, 2007

FDA approves new route of administration for rapid-acting Apidra® providing an additional treatment option for hospitalized diabetes patients with high blood sugar levels
Jun 14, 2007

Sanofi Pasteur Awarded Contract to Retrofit Influenza Vaccine Facility

Sanofi pasteur continues to join with the U.S. government in enhancing the nation’s pandemic preparedness to protect public health
Jun 13, 2007

FDA Advisory Committee did not recommend approval of rimonabant (Zimulti®) for use in obese and overweight patients with associated risks factors
Jun 4, 2007

THE ELOXATIN®-BASED REGIMEN (FOLFOX4) SIGNIFICANTLY IMPROVED PROGRESSION FREE SURVIVAL WHEN GIVEN BEFORE AND AFTER SURGERY IN PATIENTS WITH RESECTABLE LIVER METASTASES FROM COLORECTAL CANCER
Jun 4, 2007

ELOXATIN® (oxaliplatin injection)-BASED CHEMOTHERAPY SETS NEW TREATMENT BENCHMARK IN PATIENTS WITH METASTATIC COLORECTAL CANCER
Jun 4, 2007

UPDATED STUDY RESULTS REINFORCE SURVIVAL BENEFIT OF TAXOTERE® (DOCETAXEL) FOR MEN WITH ADVANCED, HORMONE-RESISTANT PROSTATE CANCER
Jun 3, 2007

“My child matters” program one-year report shows measurable improvement in cancer care for children in developing and newly industrialized countries
Jun 3, 2007

FOLFOX4 (ELOXATIN®-based chemotherapy) AFTER SURGERY IMPROVES OVERALL SURVIVAL IN PATIENTS WITH EARLY (STAGE III) COLON CANCER
Jun 3, 2007

S-1, A NOVEL ORAL FLUOROPYRIMIDINE, WHEN COMBINED WITH CISPLATIN, DEMONSTRATES SIGNIFICANT IMPROVEMENT IN OVERALL SURVIVAL OF ADVANCED GASTRIC CANCER PATIENTS OVER S-1 ALONE
Jun 3, 2007

OXFORD BIOMEDICA AND SANOFI-AVENTIS REPORT NEW TROVAX® PHASE II TRIAL RESULTS IN RENAL CANCER
Jun 2, 2007

RESULTS OF VEGF TRAP (AFLIBERCEPT) HIGHLIGHTED AT ASCO 2007 ANNUAL MEETING
May 29, 2007

FDA approves XYZAL® (levocetirizine dihydrochloride) tablets for the relief of seasonal and year round allergies, and chronic hives
May 29, 2007

Data to be presented at ASCO 2007 highlights sanofi-aventis commitment to cancer care and research
May 18, 2007

FDA Approves LOVENOX® (enoxaparin sodium injection) for the most severe type of heart attack
May 15, 2007

Sanofi-aventis calls for an effective policy against drug counterfeiting
May 8, 2007

Sopranos Star Aida Turturro speaks out to encourage fellow diabetes patients to take control
May 3, 2007

Full-year guidance raised on good 2007 first-quarter results
Apr 30, 2007

FDA Approves Lantus SoloStar® - A new prefilled disposable insulin pen for use with LANTUS® in people with Type 1 and Type 2 diabetes

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.